Infliximab ELISA Kit (ab237644)
Key features and details
- Sensitivity: 30 ng/ml
- Range: 0.1 µg/ml - 3 µg/ml
- Sample type: Plasma, Serum
- Detection method: Colorimetric
- Assay type: Quantitative
- Reacts with: Human
Overview
-
Product name
Infliximab ELISA Kit
See all Infliximab kits -
Detection method
Colorimetric -
Precision
Intra-assay Sample n Mean SD CV% Overall < 15% Inter-assay Sample n Mean SD CV% Overall < 15% -
Sample type
Serum, Plasma -
Assay type
Quantitative -
Sensitivity
30 ng/ml -
Range
0.1 µg/ml - 3 µg/ml -
Recovery
Sample specific recovery Sample type Average % Range Serum 85% - 115% -
Assay duration
Multiple steps standard assay -
Species reactivity
Reacts with: Human -
Product overview
Note: Infliximab ELISA kit ab237644 is intended for Research Use Only, not for use in diagnostic procedures.
This kit is a sandwich based ELISA kit. The color developed is proportional to the amount of Infliximab in the sample or standard. Results of samples can be determined directly using the standard curve.
-
Notes
This product is manufactured by BioVision, an Abcam company and was previously called E4375 BioSim™ Infliximab (Remicade®) (Human) ELISA Kit. E4375-100 is the same size as the 96 test size of ab237644.
-
Platform
Microplate
Properties
-
Storage instructions
Store at +4°C. Please refer to protocols. -
Components 96 tests 96 tests Assay Buffer 1 x 50ml 1 x 50ml HRP-conjugate Probe 1 x 12ml 1 x 12ml Infliximab Standard S1 1 x 300µl 1 x 300µl Infliximab Standard S2 1 x 300µl 1 x 300µl Infliximab Standard S3 1 x 300µl 1 x 300µl Infliximab Standard S4 1 x 300µl 1 x 300µl Infliximab Standard S5 1 x 300µl 1 x 300µl Infliximab Standard S6 1 x 300µl 1 x 300µl Infliximab Standard S7 1 x 300µl 1 x 300µl Micro ELISA Plate 1 unit 1 unit Plate sealers 2 units 2 units Stop Solution 1 x 12ml 1 x 12ml TMB substrate 1 x 12ml 1 x 12ml Wash buffer (20X) 1 x 50ml 1 x 50ml -
Relevance
Infliximab is a chimeric monoclonal antibody and used to treat auto- immune disorders. Infliximab reduces the amount of active human tumour necrosis factor alpha (hTNFa) in the body by binding to it and preventing it from signaling the receptors for TNFa on the surface of various cell types. TNFa is one of the key cytokines that triggers and sustains the inflammatory reactions. Infliximab is used for the treatment of psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis. -
Alternative names
- human tumour necrosis factor alpha
Images
Datasheets and documents
-
SDS download
-
Datasheet download
References (0)
ab237644 has not yet been referenced specifically in any publications.